These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12638270)

  • 41. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy.
    Szajewska H; Setty M; Mrukowicz J; Guandalini S
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):454-75. PubMed ID: 16707966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
    Amit-Romach E; Uni Z; Reifen R
    Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future.
    Shanahan F
    Br J Nutr; 2002 Sep; 88 Suppl 1():S5-9. PubMed ID: 12215176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health, probiotics, and inflammation.
    Mengheri E
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S177-8. PubMed ID: 18685508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probiotics as functional food in the treatment of diarrhea.
    Yan F; Polk DB
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):717-21. PubMed ID: 17053425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
    Howarth GS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1777-9. PubMed ID: 19120868
    [No Abstract]   [Full Text] [Related]  

  • 48. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative maintenance therapy for inflammatory bowel disease.
    Cottone M; Orlando A; Modesto I
    Curr Opin Gastroenterol; 2006 Jul; 22(4):377-81. PubMed ID: 16760753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probiotics in IBD.
    Kennedy RJ; Kirk SJ; Gardiner KR
    Gut; 2001 Dec; 49(6):873. PubMed ID: 11758502
    [No Abstract]   [Full Text] [Related]  

  • 51. The Gut Microbiome and Probiotics.
    Fatima A; Sylvester FA
    Adolesc Med State Art Rev; 2016; 27(1):140-54. PubMed ID: 27363238
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of probiotics in correcting abnormalities of colonic flora induced by stress.
    Eutamene H; Bueno L
    Gut; 2007 Nov; 56(11):1495-7. PubMed ID: 17938427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro evaluation of the upper gastrointestinal passage of a novel butyrate producing isolate to counterbalance dysbiosis in inflammatory bowel disease.
    Geirnaert A; Debruyne B; Eeckhaut V; Van Immerseel F; Boon N; Van de Wiele T
    Commun Agric Appl Biol Sci; 2012; 77(1):195-9. PubMed ID: 22558780
    [No Abstract]   [Full Text] [Related]  

  • 54. [Probiotics and inflammatory bowel disease].
    Borruel N; Casellas F; Guarner F
    Gastroenterol Hepatol; 2002 Nov; 25(9):552-9. PubMed ID: 12435307
    [No Abstract]   [Full Text] [Related]  

  • 55. [The probiotics effectiveness in the therapy of inflammatory bowel diseases].
    Khalif IL; Golovenko AO; Dikshteĭn II; Belous SS
    Eksp Klin Gastroenterol; 2013; (3):3-10. PubMed ID: 24294765
    [No Abstract]   [Full Text] [Related]  

  • 56. Probiotics and inflammatory bowel disease.
    Jonkers D; Stockbrügger R
    J R Soc Med; 2003 Apr; 96(4):167-71. PubMed ID: 12668702
    [No Abstract]   [Full Text] [Related]  

  • 57. Inflammatory bowel diseases: advances in treatment, causes. Probiotics may be a major weapon in the arsenal against these chronic intestinal diseases.
    Duke Med Health News; 2012 Feb; 18(2):4-5. PubMed ID: 22397009
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of prebiotics and probiotics on enteric flora.
    de Simone C
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S40. PubMed ID: 15805848
    [No Abstract]   [Full Text] [Related]  

  • 59. Microbiological and immunological strategies for treatment of inflammatory bowel disease.
    Steidler L
    Microbes Infect; 2001 Nov; 3(13):1157-66. PubMed ID: 11709296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lactobacillus acidophilus: a promising tool for the treatment of inflammatory bowel diseases?].
    Thomas M; Langella P; Neyrolles O
    Med Sci (Paris); 2015; 31(8-9):715-7. PubMed ID: 26340825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.